
Senior Financial Analyst Deferred Margin
Abbott Laboratories
Summary
We have an immediate opportunity for a Senior Financial Analyst Deferred Margin in our Lake County, Abbott Park, IL location. As the Senior Financial Analyst, your primary responsibilities will support Abbott Nutrition, with opportunities to collaborate across other Abbott business divisions including Established Pharmaceutical and Abbott Vascular, as needed.
Job description
The Opportunity
We have an immediate opportunity for a Senior Financial Analyst Deferred Margin in our Lake County, Abbott Park, IL location. As the Senior Financial Analyst, your primary responsibilities will support Abbott Nutrition, with opportunities to collaborate across other Abbott business divisions including Established Pharmaceutical and Abbott Vascular, as needed.
What You'll Work On
Master Data for Net Cost and Margin Factors
Generate net cost and margin factors that represent the intercompany margin in products that are currently sold or plan to be sold by ANI/EPD/AVD. This activity requires knowledge, collection and validation of transfer prices, standard costs, manufacturing usages, supply chain information, currencies, and exchange rates.
- Monitor, analyze and correct Billing Price/Cost variances.
- Support Central Cost System data collection throughout Plan and Actual cycles
- Provide analysis of year-to-year changes in margin factors to support planning activities and profitability reviews.
- Resolve international affiliates requests related to supply chain, group costs, and billing price records
HFM Journal Entries for Deferred Margin and Month End Close support
Record the deferral and release of Deferred Margin on the Balance Sheet ($.5Billion) and Income Statement ($2Billion) to ensure that Abbott reports proper consolidated financials.
- Prepare margin journal entries in Hyperion Financial Management (HFM) for Exchange, P&L adjustments, Balance Sheet activity, Standards Revision Variance (SRV), exchange scenarios @Plan and @Prior Year, as well as ad hoc entries
- Due to the dynamic nature of the intercompany structure and billing flows, process improvements are frequently required to adapt existing processes to the new environment
- Provide active and continuous support of the margin financial impact for ANI/EPD/AVD, ad hoc analysis to support Commercial Areas and Global Supply Chain organizations, and recognize the financial impact of decisions
Balance Sheet Review & Reconciliations
Analyze complex Deferred Margin inventory account reconciliations - develop recommendations to clear reconciling items and implement solutions.
- Monitor the annual and mid-year inventory Standard Revision Variance calculations due to changes in Transfer Price and Manufacturing Cost, resolve differences with international affiliates
- Influence and provide guidance for decision making within the team, management, and or functional groups for system, process, or data issues
- Support Deferred Margin data with external auditors
Requirements
- Bachelor's degree in Accounting or Finance
- Excellent verbal and written communication skills
- Ability to work in an Accounting/Finance role supporting several divisions and international affiliates
- Quantitative, analytical, and problem-solving skills
- Organize and prioritize in a fast-paced work environment
- Partner with persons contacted in the course of performing the assigned duties
- High proficiency in Microsoft Excel including creating/maintaining Pivot Tables and formula writing (VLOOKUP, SUMIFS, conditional IF or IFERROR statements)
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Tuition Reimbursement
- Student Debt Program
- Education Benefit
- Career Development
Company overview
Abbott Laboratories is a global healthcare technology leader founded in 1888 and headquartered in Chicago, Illinois. As an international medtech and pharmaceutical company, Abbott operates in approximately 160 countries worldwide with a workforce of over 115,000 employees. The company is organized into four major business segments: Medical Devices (48% of revenue), Diagnostics (20%), Nutritional Products (19%), and Established Pharmaceutical Products (12%). Abbott's medical devices portfolio includes revolutionary technologies such as the FreeStyle Libre continuous glucose monitoring system for diabetes management, cardiovascular devices like the MitraClip and TriClip for heart valve repair, and neuromodulation systems for chronic pain management. The company's diagnostics division pioneered breakthrough tests including the first licensed HIV blood test in 1985. With a rich history spanning over 135 years, Abbott has consistently been recognized as one of Fortune's World's Most Admired Companies since 1984 and continues to drive innovation in healthcare technology to help people live healthier, fuller lives.